Advanced NanoTherapies Inc.

About Advanced NanoTherapies Inc.

Advanced NanoTherapies is a company focused on developing next-generation drug-coated balloons for the treatment of coronary and peripheral artery diseases. Their mission is to deliver innovative therapies that provide stent-like performance without the burden of stents, using advanced nanoparticle drug delivery platforms for sustained drug release and improved patient outcomes.

Products & Services

SirPlux™ Duo Drug Coated Balloon (DCB):A therapy for coronary and peripheral artery disease that delivers Sirolimus and Paclitaxel simultaneously for higher potency at a lower dose, with long-term in-tissue release using a nanoparticle drug delivery platform.

Specialties

Nanoparticle Drug Delivery Drug-Coated Balloons Coronary Artery Disease Treatment Peripheral Artery Disease Treatment Sustained Drug Release Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A extension T: - FT: Series A extension	A: 4000000 MR: - FA: $4M FAN: 4000000	D: 2023-08-22 FD: 2023-08-22	1 investors

Series A extension Latest

2023-08-22

$4.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Marwan Berrada

Chief Executive Officer

M

Michael Mandel

Head of Corporate Development

V

Vinod Labhasetwar

Scientific Advisor

A

Azeem Latib

Director, Interventional Cardiology & Structural Heart Interventions, Montefiore Medical Center

G

Gary Ansel

System Medical Chief, Vascular Program, OhioHealth

P

Peter Schneider

Professor of Surgery, Div. of Vascular & Endovascular Surgery, UCSF

View 8 more team members with Pro

Unlock Full Team Directory

Recent News